Saturday 17 October 2026
Export CON’s income statement to Excel — free account
Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
38.54
0.61
−1.56%
Follow CON
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
19.19 | 15.43 | 15.14 | 17.44 |
+8 more quarters Free account |
P/S ratio |
1.63 | 1.21 | 1.17 | 1.28 | |
P/FCF ratio |
13.80 | 12.74 | 12.76 | 15.22 | |
P/Operating CF |
27.53 | 128.36 | 21.27 | 44.25 | |
P/B ratio |
7.68 | 6.24 | 6.30 | 6.87 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.25 | 1.89 | 1.86 | 2.03 | |
EV/EBITDA |
11.20 | 9.75 | 9.71 | 10.65 | |
EV/Operating CF |
15.31 | 14.59 | 14.39 | 16.69 | |
EV/FCF |
19.05 | 19.89 | 20.32 | 24.08 | |
Quick Ratio |
1.24 | 1.12 | 1.00 | 1.05 | |
Current Ratio |
1.38 | 1.26 | 1.14 | 1.20 | |
Net Debt/EBITDA |
10.41 | 13.02 | 16.43 | 13.54 | |
Debt/Assets |
52.28% | 54.54% | 55.08% | 56.70% | |
Debt/Equity |
3.25 | 3.65 | 3.93 | 4.13 | |
Asset Turnover |
0.78 | 0.79 | 0.80 | 0.78 | |
Operating CF/Net income |
2.07 | 0.42 | 3.37 | 1.27 | |
Capex/Depreciation |
(0.68) | (0.54) | (0.95) | (0.98) | |
Interest Coverage |
— | 3.68 | 1.27 | 3.29 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.35% | 9.71% | 9.42% | 9.23% | |
Intangible Assets out of Total Assets |
0.57 | 0.59 | 0.60 | 0.61 | |
Share Based Compensation of Revenue |
0.68% | 0.73% | 0.67% | 0.41% | |
Graham Net Nets |
(0.54) | (0.76) | (0.82) | (0.77) | |
Graham Number |
11.62 | 10.37 | 9.56 | 9.07 | |
Earnings Yield |
5.21% | 6.48% | 6.61% | 5.73% | |
Free Cash Flow Yield |
7.25% | 7.85% | 7.84% | 6.57% | |
Revenue per Share |
4.84 | 4.53 | 4.20 | 4.47 | |
Operating CF per Share |
1.08 | 0.17 | 0.93 | 0.47 | |
Capex per Share |
(0.11) | (0.09) | (0.16) | (0.16) | |
Free Cash Flow per Share |
0.97 | 0.08 | 0.77 | 0.31 | |
Cash per Share |
1.26 | 0.49 | 0.62 | 0.39 | |
Shareholders Equity per Share |
3.87 | 3.44 | 3.13 | 3.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.87 | 3.44 | 3.13 | 3.05 | |
Free Cash Flow |
121.01 | 9.93 | 98.56 | 40.16 | |
Working Capital |
138.54 | 83.34 | 45.85 | 62.79 | |
Capital Expenditures |
(14.20) | (11.09) | (20.13) | (20.47) | |
Net Current Asset Value |
(2,019.07) | (2,053.34) | (2,074.26) | (2,077.83) | |
EV/EBIT |
13.71 | 12.06 | 12.03 | 13.13 | |
Capex to Sales |
0.02 | 0.02 | 0.04 | 0.04 | |
Price to Operating Income |
9.93 | 7.72 | 7.56 | 8.29 | |
| Other line items | |||||
Average Receivables |
285.79 | 277.32 | 237.81 | 255.59 | |
Average Payables |
37.65 | 33.46 | 20.38 | 26.91 | |
Average Assets |
2,925.93 | 2,809.50 | 2,689.78 | 2,662.49 | |
Average Common Equity |
416.27 | 372.33 | 340.87 | 336.89 |
Columns are period end dates